{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:16:46Z","timestamp":1789132606153,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":2047,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.bbmt.2009.05.015","type":"journal-article","created":{"date-parts":[[2009,8,5]],"date-time":"2009-08-05T05:30:17Z","timestamp":1249450217000},"page":"1108-1115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Lymphocyte Recovery Is a Major Determinant of Outcome after Matched Unrelated Myeloablative Transplantation for Myelogenous Malignancies"],"prefix":"10.1016","volume":"15","author":[{"given":"Katarina","family":"Le Blanc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. John","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Schaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"H\u00e4gglund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Ljungman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olle","family":"Ringd\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Remberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2009.05.015_bib1","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1182\/blood.V91.9.3481","article-title":"Identification of patients who may benefit from prophylactic immunotherapy after bone marrow transplantation for acute myeloid leukemia on the basis of lymphocyte recovery early after transplantation","volume":"91","author":"Powles","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.05.015_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2141.2004.04891.x","article-title":"Clinical impact of early absolute lymphocyte count after allogeneic stem cell transplantation","volume":"125","author":"Kim","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2009.05.015_bib3","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/sj.bmt.1703262","article-title":"Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia","volume":"28","author":"Kumar","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.05.015_bib4","first-page":"939","article-title":"Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation","volume":"90","author":"Lee","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2009.05.015_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/sj.bmt.1704082","article-title":"Early lymphocyte recovery is an important determinant of outcome following allogeneic transplantation with CD34+ selected graft and limited T-cell addback","volume":"32","author":"Chakrabarti","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.05.015_bib6","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.bbmt.2007.07.005","article-title":"Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation","volume":"13","author":"Savani","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.05.015_bib7","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1038\/sj.leu.2404892","article-title":"Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia","volume":"21","author":"Savani","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2009.05.015_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002770050246","article-title":"Association of natural killer cell immune recovery with a graft-versus-leukemia effect independent of graft-versus-host disease following allogeneic bone marrow transplantation","volume":"74","author":"Jiang","year":"1997","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2009.05.015_bib9","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/sj.leu.2404300","article-title":"Non-classical antileukemia activity of early recovering NK cells after induction chemotherapy and HLA-identical stem cell transplantation in myeloid leukemias","volume":"20","author":"Sconocchia","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2009.05.015_bib10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2141.1987.00295.x-i1","article-title":"Rapid reappearance of large granular lymphocytes (LGL) with concomitant reconstitution of natural killer (NK) activity after human bone marrow transplantation (BMT)","volume":"65","author":"Niederwieser","year":"1987","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2009.05.015_bib11","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/CCO.0b013e3280148a1a","article-title":"Natural killer cell alloreactivity in allogeneic hematopoietic transplantation","volume":"19","author":"Ruggeri","year":"2007","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.bbmt.2009.05.015_bib12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1399-0039.1992.tb01940.x","article-title":"HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation","volume":"39","author":"Olerup","year":"1992","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.bbmt.2009.05.015_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1034\/j.1399-0039.2003.00089.x","article-title":"Roles of HLA-B, HLA-C and HLA-DPA1 incompatibilities in the outcome of unrelated stem-cell transplantation","volume":"62","author":"Schaffer","year":"2003","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.bbmt.2009.05.015_bib14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/01.TP.0000133513.29923.44","article-title":"Dose study of thymoglobulin during conditioning for unrelated donor allogeneic stem-cell transplantation","volume":"78","author":"Remberger","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2009.05.015_bib15","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/sj.bmt.1701991","article-title":"Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation","volume":"24","author":"Remberger","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.05.015_bib16","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1182\/blood.V73.6.1729.1729","article-title":"Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial","volume":"73","author":"Storb","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.05.015_bib17","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1182\/blood.V81.4.1094.1094","article-title":"Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia?","volume":"81","author":"Ringden","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.05.015_bib18","first-page":"619","article-title":"Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings","volume":"15","author":"Ringden","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.05.015_bib19","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1182\/blood.V98.6.1739","article-title":"No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors","volume":"98","author":"Remberger","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.05.015_bib20","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/sj.bmt.1701996","article-title":"A prospective randomized trial of Filgrastim (r-metHuG-CSF) given at different times after unrelated bone marrow transplantation","volume":"24","author":"Hagglund","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.05.015_bib21","first-page":"825","article-title":"1994 Consensus conference on acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.05.015_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0609.1993.tb00597.x","article-title":"Management of graft-versus-host disease","volume":"51","author":"Ringden","year":"1993","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.bbmt.2009.05.015_bib23","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/01.tp.0000214462.63943.14","article-title":"Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease","volume":"81","author":"Ringden","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2009.05.015_bib24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.bbmt.2009.05.015_bib25","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators","volume":"18","author":"Gooley","year":"1999","journal-title":"Stat Med"},{"key":"10.1016\/j.bbmt.2009.05.015_bib26","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"Proportional hazard model for the sub-distribution of competing risks","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.bbmt.2009.05.015_bib27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/leu.2008.273","article-title":"Does chemotherapy modify the immune surveillance of hematological malignancies?","volume":"23","author":"Barrett","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2009.05.015_bib28","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1046\/j.1365-2141.2003.04364.x","article-title":"Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell doses","volume":"121","author":"Ringden","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2009.05.015_bib29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.bmt.1701290","article-title":"Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation","volume":"22","author":"Remberger","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.05.015_bib30","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/sj.leu.2404777","article-title":"Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells","volume":"21","author":"Le Blanc","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2009.05.015_bib31","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2009.05.015_bib32","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1200\/JCO.2004.06.102","volume":"22","author":"Ringden","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2009.05.015_bib33","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.exphem.2005.01.009","article-title":"Granulocyte and granulocyte-macrophage colony-stimulating factors in allografts: uses, misuses, misconceptions, and future applications","volume":"33","author":"Ringden","year":"2005","journal-title":"Exp Hematol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879109002547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879109002547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:33:55Z","timestamp":1761057235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879109002547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S1083879109002547"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2009.05.015","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphocyte Recovery Is a Major Determinant of Outcome after Matched Unrelated Myeloablative Transplantation for Myelogenous Malignancies","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2009.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}